Journavx revived an area of development long considered a graveyard. Can any other pain drugs keep investor excitement going?

After leading the agency for a short 13 months, it was announced on Tuesday afternoon that Makary would be resigning from the ...

Oncotelic Therapeutics Inc. (OTCQB: OTLC) today announces its placement in an editorial published by BioMedWire (BMW), one of 75+ brands within the Dynamic Brand Portfolio@IBN (InvestorBrandNetwork), ...

(NASDAQ: LONA), a clinical-stage biopharmaceutical company dedicated to the development of novel therapeutics for diseases with high unmet medical needs, today announced the appointment of Fred ...

AEVEX Corp. is presenting its comprehensive portfolio of autonomous systems, launched effects, airborne ISR, and mission?enabling technologies as special operations, defense, and security leaders ...

Penny Stock Quantum-Si Incorporated Readies For Lift-Off Quantum-Si (NASDAQ:QSI) reported first-quarter 2026 revenue of $258,000 and reiterated that the year will be a transition period focused on ...

June S&P 500 E-Mini futures (ESM26) are trending up +0.46% this morning as investors shrugged off an exchange of fire between ...

CRISPR-edited tumor-infiltrating lymphocytes are emerging as a promising alternative to CAR T-cell therapy for solid cancers.

On March 20, the FDA approved Opdivo for adult and pediatric patients (aged 12 years and older) with previously untreated ...

Lenvatinib Plus Pembrolizumab Versus Standard of Care for Previously Treated Metastatic Colorectal Cancer: Final Analysis of the Randomized, Open-Label, Phase III LEAP-017 Study Patients with advanced ...

The recovery also indicates a broader shit — innovators are increasingly outsourcing development and manufacturing to ...

LeonaBio, Inc. (NASDAQ: LONA), a clinical-stage biopharmaceutical company dedicated to the development of novel therapeutics for diseases with high unmet medical needs, ...